- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: non-pegylated liposomal doxorubicon (Myocet™)
Total 305 results
-
French Innovative Leukemia OrganisationCompleted
-
University of Texas Southwestern Medical CenterGateway for Cancer Research; Celldex TherapeuticsRecruitingMetastatic Breast Cancer | HER2-negative Breast CancerUnited States
-
Shattuck Labs, Inc.Active, not recruitingOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal CarcinomaUnited States, United Kingdom, Spain, Canada
-
US Oncology ResearchOrtho Biotech, Inc.; Tibotec Pharmaceutical LimitedCompleted
-
Tesaro, Inc.Terminated
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingOvarian Serous Adenocarcinoma | Primary Peritoneal Serous Adenocarcinoma | Recurrent Ovarian Low Grade Serous Adenocarcinoma | Borderline Ovarian Serous Tumor | Micropapillary Serous Carcinoma | Recurrent Primary Peritoneal Serous AdenocarcinomaUnited States, United Kingdom
-
National Cancer Institute (NCI)CompletedAIDS-related Kaposi SarcomaUnited States
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI)Not yet recruitingKaposi Sarcoma | HIV-1-infection | AIDS-related Kaposi Sarcoma
-
Atreca, Inc.TerminatedMelanoma | Breast Cancer | Hepatocellular Carcinoma | Colorectal Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Triple Negative Breast Cancer | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma | Urothelial Carcinoma | Acral Lentiginous Melanoma | Platinum-Resistant Fallopian... and other conditionsUnited States
-
Shanghai General Hospital, Shanghai Jiao Tong University...Recruiting
-
Haider MahdiMerck Sharp & Dohme LLC; ALX OncologyRecruiting
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.; Ortho Biotech, Inc.TerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedSarcoma | Ovarian Cancer | Fallopian Tube Cancer | Endometrial CancerUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)Terminated
-
Mural Oncology, IncMerck Sharp & Dohme LLCRecruitingFallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal CancerUnited States, Spain, Korea, Republic of, Taiwan, Canada, Israel, France, United Kingdom, Germany, Belgium, Czechia, Singapore, Australia, Austria, Italy
-
Fudan UniversityRecruitingHigh-Risk Localized Soft Tissue SarcomaChina
-
Ludwig Institute for Cancer ResearchCelgene; Cancer Research Institute, New York City; MedImmune LLCCompletedOvarian CancerUnited States, Switzerland
-
ARCAGY/ GINECO GROUPEuropean Organisation for Research and Treatment of Cancer - EORTC; Scherin... and other collaboratorsCompletedOvarian Cancer | Fallopian Tube CancerFrance
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States, Norway
-
BayerCompletedOvarian NeoplasmsBelgium, Spain, Moldova, Republic of, United States
-
Sun Yat-sen UniversityUnknownUnrecognized Condition
-
Merck Sharp & Dohme LLCMDS Pharma ServicesCompleted
-
Aptium Oncology Research NetworkOrtho Biotech Products, L.P.Unknown
-
National Cancer Institute (NCI)RecruitingMalignant Solid NeoplasmUnited States
-
Fox Chase Cancer CenterCompletedFallopian Tube Cancer | Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
National Cancer Institute (NCI)CompletedCombination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast CancerStage IV Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Undifferentiated Ovarian CarcinomaUnited States
-
Tianjin Medical University Cancer Institute and...UnknownChemotherapy Effect | Susceptibility, GeneticChina
-
Merck Sharp & Dohme LLCCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Stage III Fallopian Tube Cancer AJCC v7 | Stage III Ovarian Cancer AJCC v6 and v7 | Stage III Primary Peritoneal Cancer AJCC v7 | Stage III Uterine Corpus... and other conditionsUnited States
-
National Cancer Institute (NCI)NRG OncologyWithdrawnRecurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Recurrent Fallopian Tube Endometrioid Adenocarcinoma | Recurrent Ovarian Endometrioid Adenocarcinoma | Recurrent Platinum-Resistant Fallopian Tube Carcinoma | Recurrent Platinum-Resistant Primary... and other conditionsUnited States
-
University of Southern CaliforniaTerminatedNon-Hodgkin's Lymphoma | Burkitt Lymphoma | Primary Effusion LymphomasUnited States
-
Pharmatech OncologyUnknownBreast CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
King Faisal Specialist Hospital & Research CenterCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
Roswell Park Cancer InstituteOrtho Biotech, Inc.Completed
-
The University of Texas Health Science Center,...UnknownCervical Cancer | Breast Cancer | Ovarian Cancer | Endometrial CancerUnited States
-
Cephalon, Inc.CompletedBreast CancerAustria, Belgium, France, Germany, Italy, Spain
-
Spanish Breast Cancer Research GroupSanofi; Hoffmann-La Roche; Amgen; CephalonCompleted
-
Women's Hospital School Of Medicine Zhejiang UniversityActive, not recruiting
-
Konkuk University Medical CenterNational Cancer Center, Korea; Samsung Medical Center; Asan Medical Center; Seoul... and other collaboratorsCompletedOvarian CarcinomaKorea, Republic of
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Malignant Ovarian Mixed Epithelial Tumor | Ovarian Brenner Tumor | Ovarian Mucinous... and other conditionsUnited States
-
Aravive, Inc.CompletedEfficacy and Safety Study of AVB-S6-500 in Patients With Platinum-Resistant Recurrent Ovarian CancerOvarian CancerUnited States
-
National Cheng-Kung University HospitalCompletedFallopian Tube Cancer | Peritoneal Carcinoma | Ovarian Neoplasms Malignant (Excl Germ Cell)
-
Washington University School of MedicineCompletedResistant Solid MalignanciesUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerUnited States
-
Fudan UniversityRecruiting
-
M.D. Anderson Cancer CenterCompletedInvasive Breast Carcinoma | Triple-Negative Breast CarcinomaUnited States
-
Novartis PharmaceuticalsActive, not recruitingOvarian CancerUnited States, Italy, United Kingdom, Malaysia, Taiwan, Turkey, Belgium, Canada, Spain, Singapore, Austria, Denmark, Korea, Republic of, Australia, China, France, Netherlands, Russian Federation, Germany, Argentina, Mexico, Finland, Portuga... and more